The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

Proceedings of the National Academy of Sciences of the United States of America

Volumn 98, Issue 4, 2001, Pages 1781-1786

  Addo, Marylyn M ^a   Altfeld, Marcus ^a   Rosenberg, Eric S ^a   Eldridge, Robert L ^a   Philips, Mary N ^a   Habeeb, Kathleen ^a   Khatri, Ashok ^a   Brander, Christian ^a   Robbins, Gregory K ^a   Mazzara, Gail P ^b   Goulder, Philip J R ^a   Walker, Bruce D ^a   Carpenter, Charles C ^c   Fuller, Jon ^d   Modest, Geoffrey A ^e   Rockstroh, Jürgen K ^f   Fätkenheuer, Gerd ^g   Salzberger, Bernd ^g   Jütte, Alexander ^g   Kalams, Spyros A ^a   Basgoz, Nesli ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Therion Biologics Corporation   (United States)

^c BROWN UNIVERSITY   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e Upham's Corner Health Center   (United States)

^f UNIVERSITY OF BONN   (Germany)

^g UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; REGULATOR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; LIFE CYCLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; T LYMPHOCYTE;

CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, REV; GENE PRODUCTS, TAT; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0035852758     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.98.4.1781     Document Type: Article

References (39)